Posted on: 2/9/2018
Starting in mid-March 2018, all drug screen specimens tested at our Burnaby testing lab will transition from the current Roche Integra 800 instrumentation to our new Siemens instrumentation. Depending on the test, the methodology may differ. Cut-off levels will not change as a result of this transition. Please note that the new methodology will exhibit different cross-reactivity than the existing method. See below for complete cross reactivity tables.
Click here to download the Advia 1800 Cross-Reactivity Tables